Search Results - "Barrett, L V"

Cardiac Allograft Survival in Mice Treated with IL-2-PE40 by Lorberboum-Galski, Haya, Barrett, Leslie V., Kirkman, Robert L., Ogata, Masato, Willingham, Mark C., FitzGerald, David J., Pastan, Ira

“…IL-2-PE40 is a chimeric protein composed of human interleukin 2 (IL-2) genetically fused to the amino terminus of a modified form of Pseudomonas exotoxin…”
Get full text

Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice by KIRKMAN, R. L, BARRETT, L. V, GAULTON, G. N, KELLEY, V. E, YTHIER, A, STROM, T. B

“…Administration of the monoclonal antibody M7/20, which binds to the murine interleukin-2 (IL) receptor, significantly prolongs cardiac allograft survival in…”
Get full text

Enhancement of immunosuppression by substitution of fish oil for olive oil as a vehicle for cyclosporine by Kelley, V E, Kirkman, R L, Bastos, M, Barrett, L V, Strom, T B

“…As previously reported, acute cyclosporine-induced nephrotoxicity is characterized by a decline in glomerular filtration rate and a selective intrarenal…”
Get more information

Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection by Gang, DL, Barrett, LV, Wilson, EJ, Rubin, RH, Medearis, DN

“…In mice inoculated with murine cytomegalovirus (MCMV) an acute myopericarditis developed which varied from a focal lymphohistiocytic inflammation to intense…”
Get full text

Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin-2 fusion protein by Kirkman, R L, Bacha, P, Barrett, L V, Forte, S, Murphy, J R, Strom, T B

“…A diphtheria toxin-related IL-2 fusion gene has been constructed that encodes a 68KD recombinant toxin in which the diphtheria toxin receptor-binding domain…”
Get more information

Insights into the mechanism of allograft acceptance in T-cell receptor (beta-chain) transgenic mice by Barrett, L V, Rimm, I J, Wiens, G R, Seidman, J G, Kirkman, R L

Get more information

RO 23-6457 prolongs survival of vascularized allografts in rodents and primates by Kirkman, R L, Barrett, L V, Carter, P, Reed, M H, Shapiro, M E

“…The ability of RO 23-6457, a retinoid compound with marked in vitro immunosuppressive properties, to prolong vascularized allografts was examined in several in…”
Get more information

Activation of Latent Murine Cytomegalovirus in Cardiac Explant and Cell Cultures by Wilson, Eileen J., Medearis, Donald N., Barrett, Leslie V., Rubin, Robert H.

“…Cytomegalovirus (CMV) produces a latent infection in its host. The actively or latently infected transplanted kidney and heart are sources of debilitating CMV…”
Get full text

The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection by Kirkman, R L, Barrett, L V, Gaulton, G N, Kelley, V E, Koltun, W A, Schoen, F J, Ythier, A, Strom, T B

“…During immune response to an allograft, activated T cells express a number of cell surface activation antigens, among them the membrane receptor for the…”
Get more information

Allorecognition in T-cell receptor (beta-chain) transgenic mice by Barrett, L V, Rimm, I J, Wiens, G R, Seidman, J G, Kirkman, R L

“…Recent advances in knowledge of the structure of the T-cell receptor and of major histocompatibility complex (MHC) molecules have increased our understanding…”
Get more information

Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13 by Kirkman, R L, Barrett, L V, Koltun, W A, Diamantstein, T

Get more information

Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in mice by Barrett, L V, Murphy, J R, Strom, T B, Kirkman, R L

Get more information

Primary cytomegalovirus infection following cardiac transplantation in a murine model by Rubin, R H, Wilson, E J, Barrett, L V, Medearis, D N

“…A murine cytomegalovirus (CMV) model was utilized to determine the source of primary CMV infection in cardiac transplantation. Hearts were taken from actively…”
Get more information

The effects of donor pretreatment on the transmission of murine cytomegalovirus with cardiac transplants and explants by Wilson, E J, Medearis, D N, Barrett, L V, Bhan, A, Rubin, R H

Get more information

Dehydrogenase-modified carbon-fiber microelectrodes for the measurement of neurotransmitter dynamics. 1. NADH voltammetry by Kuhr, Werner G, Barrett, Valerie L, Gagnon, Michelle R, Hopper, Phillip, Pantano, Paul

“…The voltammetry of NADH has been characterized at carbon-fiber microelectrodes at scan rates up to 100 V/s. Electrochemical pretreatment of the electrode…”
Get full text

Preclinical evaluation of immunosuppression selective for T cells recognizing class I histocompatibility antigens by Wright, Jr, J K, Barrett, L V, Delmonico, F L, Fuller, T C, Cosimi, A B

Get more information

Improved reliability in rock mass characterisation for underground support design – Discrete fracture network model and site observation by Haryono, I.S., Rogers, S.F., Barrett, S.V.L., McQueen, L.B.

“…Conventional empirical methods for rock mass characterisation can only offer limited understanding and qualitative statements of rock mass condition based on…”
Get full text

Rock mechanics for design of Brisbane tunnels and implications of recent thinking in relation to rock mass strength by L.B. McQueen, A. Purwodihardjo, S.V.L. Barrett

“…This paper explores the potential implications of recent thinking in relation to rock mass strength for future tunnelling projects in Brisbane, Australia,…”
Get full text

Monitoring the bioenergetics of cardiac allograft rejection using in vivo P-31 nuclear magnetic resonance spectroscopy by Canby, Robert C., Evanochko, William T., Barrett, Leslie V., Kirklin, James K., McGiffin, David C., Sakai, Ted T., Brown, Michael E., Foster, Robert E., Reeves, Russell C., Pohost, Gerald M.

“…Monitoring human cardiac allograft rejection is currently accomplished by endomyocardial biopsy. Available noninvasive methods for identifying rejection have…”
Get full text

The protective effects of hyperimmune anti-murine cytomegalovirus antiserum against lethal viral challenge: the case for passive-active immunization by Rubin, R H, Wilson, E J, Barrett, L V, Medearis, D N

“…The administration of 0.2 ml of hyperimmune anti-mouse cytomegalovirus (CMV) antiserum intraperitoneally (ip) or intravenously provided complete protection…”
Get more information